Tivdak is a cancer medicine used to treat adults with cervical cancer (a cancer of the cervix) when the disease has worsened during or after previous systemic (whole\-body) treatment. It is used on its own in patients whose cancer has come back or is metastatic (has spread to other parts of the body). Tivdak contains the active substance tisotumab vedotin.
Therapeutic Indication
Tivdak as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after systemic therapy (see section 5\.1\).
Therapeutic Area (MeSH)
ATC Code
L01FX23
ATC Item
N/A
Pharmacotherapeutic Group
Antineoplastic agents
Active Substance (Summary)
INN / Common Names
EMA Name
Tivdak
Medicine Name
Tivdak
Aliases
N/ANo risk management plan link.
